Startseite Protection of Baculovirus-Vectors against Complement-Mediated Inactivation by Recombinant Soluble Complement Receptor Type 1
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Protection of Baculovirus-Vectors against Complement-Mediated Inactivation by Recombinant Soluble Complement Receptor Type 1

  • C. Hofmann , A. Hüser , W. Lehnert und M. Strauss
Veröffentlicht/Copyright: 1. Juni 2005
Biological Chemistry
Aus der Zeitschrift Band 380 Heft 3

Abstract

Baculovirus-based vectors are efficient means for gene transfer into hepatocytes in vitro. However, gene transfer in vivo is hampered by inactivation of baculovirus by the complement system.

In this study, we demonstrate protection of baculovirus vectors against complement-mediated inactivation through recombinant soluble complement receptor type 1 (sCR1). Blocking of only the alternative complement pathway by a mutant of sCR1 did not result in baculovirus survival in human serum. The data suggest the use of sCR1 as a potent drug to facilitate baculovirus-mediated gene transfer into hepatocytes in vivo.

:
Published Online: 2005-06-01
Published in Print: 1999-03-01

Copyright © 1999 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Chimeric Virus-Like Particles as Vaccines
  2. The Core Antigen of Hepatitis B Virus as a Carrier for Immunogenic Peptides
  3. Enhancing the Immunogenicity of Exogenous Hepatitis B Surface Antigen-Based Vaccines for MHC-I-Restricted T Cells
  4. The Role of the Proteasome System and the Proteasome Activator PA28 Complex in the Cellular Immune Response
  5. Ty Virus-Like Particles, DNA Vaccines and Modified Vaccinia Virus Ankara; Comparisons and Combinations
  6. Chaperones Involved in Hepatitis B Virus Morphogenesis
  7. Behavior of a Short preS1 Epitope on the Surface of Hepatitis B Core Particles
  8. HBV Core Particles Allow the Insertion and Surface Exposure of the Entire Potentially Protective Region of Puumala Hantavirus Nucleocapsid Protein
  9. Induction of HPV16 Capsid Protein-Specific Human T Cell Responses by Virus-Like Particles
  10. Construction and Characterization of Recombinant VLPs and Semliki-Forest Virus Live Vectors for Comparative Evaluation in the SHIV Monkey Model
  11. Development of HIV/AIDS Vaccine Using Chimeric gag-env Virus-Like Particles
  12. A Disulfide-Bound HIV-1 V3 Loop Sequence on the Surface of Human Rhinovirus 14 Induces Neutralizing Responses against HIV-1
  13. DNA-Plasmids of HIV-1 Induce Systemic and Mucosal Immune Responses
  14. Yeast Cells Allow High-Level Expression and Formation of Polyomavirus-Like Particles
  15. Position-Dependent Processing of Peptides Presented on the Surface of Cowpea Mosaic Virus
  16. Protection of Baculovirus-Vectors against Complement-Mediated Inactivation by Recombinant Soluble Complement Receptor Type 1
  17. Site-Specific Fluorescence Labelling of Recombinant Polyomavirus-Like Particles
Heruntergeladen am 24.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/BC.1999.052/html
Button zum nach oben scrollen